Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

WIN Symposium 2017

Videos

WIN 2017 conference review

Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO)
WIN 2017 conference review ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
5 Jul 2017

Molecular medicine in lung cancer

Dr Reinhard Büttner - University Hospital of Cologne, Cologne, Germany
Molecular medicine in lung cancer ( Dr Reinhard Büttner - University Hospital of Cologne, Cologne, Germany )
4 Jul 2017

Biomarker research in breast cancer

Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium
Biomarker research in breast cancer ( Prof Martine Piccart - Institute Jules Bordet, Brussels, Belgium )
4 Jul 2017

New biomarkers for response to immunotherapy

Prof Antoni Ribas - University of California, Los Angeles, USA
New biomarkers for response to immunotherapy ( Prof Antoni Ribas - University of California, Los Angeles, USA )
4 Jul 2017

Combining immune-based therapies with TKIs in melanomas

Prof Caroline Robert - Institute Gustave Roussy, Paris, France
Combining immune-based therapies with TKIs in melanomas ( Prof Caroline Robert - Institute Gustave Roussy, Paris, France )
4 Jul 2017

Current and future immune approaches in precision medicine

Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France
Current and future immune approaches in precision medicine ( Prof Jean -Yves Blay - Centre Léon Bérard, Lyon, France )
4 Jul 2017

Precision medicine enabled histology agnostic development of immunotherapeutics

Dr Roy Baynes - Merck Research Laboratories, Rahway, USA
Precision medicine enabled histology agnostic development of immunotherapeutics ( Dr Roy Baynes - Merck Research Laboratories, Rahway, USA )
4 Jul 2017

Incorporating liquid biopsies into clinical trials

Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor, USA
Incorporating liquid biopsies into clinical trials ( Dr Daniel Hayes - University of Michigan Comprehensive Cancer Center, Ann Arbor, USA )
4 Jul 2017

DNA damage response inhibition

Dr Giorgio Massimini - Vice President, Head of Early Clinical Oncology, Merck, Darmstadt, Germany
DNA damage response inhibition ( Dr Giorgio Massimini - Vice President, Head of Early Clinical Oncology, Merck, Darmstadt, Germany )
4 Jul 2017

Big data, scientific wellness and transforming healthcare

Prof Leroy Hood - Systems Biology, Seattle, USA
Big data, scientific wellness and transforming healthcare ( Prof Leroy Hood - Systems Biology, Seattle, USA )
4 Jul 2017

Bayesian adaptive trial designs for precision medicine

Dr Jack Lee - MD Anderson Cancer Center, Houston, USA
Bayesian adaptive trial designs for precision medicine ( Dr Jack Lee - MD Anderson Cancer Center, Houston, USA )
4 Jul 2017

Redesigning clinical trials in the era of precision medicine

Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA
Redesigning clinical trials in the era of precision medicine ( Dr Razelle Kurzrock - San Diego Moores Cancer Center, San Diego, USA )
4 Jul 2017

Genomic-driven clinical studies in breast cancer

Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA
Genomic-driven clinical studies in breast cancer ( Prof José Baselga - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jul 2017

Genomic predictors of treatment response in prostate cancer

Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada
Genomic predictors of treatment response in prostate cancer ( Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada )
4 Jul 2017

Synthetic lethality as a basis to select drug combinations

Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland
Synthetic lethality as a basis to select drug combinations ( Prof René Bernards - Netherlands Cancer Institute, Amsterdam, Holland )
4 Jul 2017

Genomic analysis of childhood tumours; biological and therapeutic implications

Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany
Genomic analysis of childhood tumours; biological and therapeutic implications ( Dr Peter Lichter - German Cancer Research Center (DKFZ), Heidelberg, Germany )
4 Jul 2017

Patient-specific peptide vaccines

Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany
Patient-specific peptide vaccines ( Prof Hans-Georg Rammensee - University of Tübingen, Tübingen, Germany )
4 Jul 2017

Proteogenomics in cancer research

Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA
Proteogenomics in cancer research ( Dr Henry Rodriguez - National Cancer Institute (NIH), Bethesda, USA )
4 Jul 2017

Novel models to personalise cancer therapeutics

Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden
Novel models to personalise cancer therapeutics ( Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden )
4 Jul 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation